Candel Therapeutics share price logo

Candel Therapeutics

NASDAQ: CADL

Small Cap

$8.33

-0.32

(-3.70%)

as on

Candel Therapeutics Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $8.16
    $8.60
    downward going graph

    2.04%

    Downside

    3.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.35
    $14.00
    downward going graph

    47.78%

    Downside

    68.07%

    Upside

    downward going graph

Candel Therapeutics share price movements today

Previous Close
$8.65
Open
$8.56
Volume
620.1K
Market Cap
$663.4M
Day's Low - High
$8.16 - $8.60
52 Week Low - High
$4.35 - $14.00

Candel Therapeutics Historical Returns

1 Month Return
-17.15 %
3 Month Return
-12.36 %
1 Year Return
+ 55.02 %
3 Year Return
+ 873 %
5 Year Return
-22.97 %

Candel Therapeutics Stock Fundamentals & Key Indicators

Check Candel Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$663.4M

EPS (TTM)

-1.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.15

Industry PE ratio

-7.60

PEG Ratio

0.08

EBITDA

-83.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-89.38%

Candel Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Candel Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$663.4M-22.97%-6.150.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Candel Therapeutics Stock including INR - Dollar returns

The Candel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Candel Therapeutics investment value today

Current value as on today

₹1,59,679

Returns

₹59,679

(+59.68%)

Returns from Candel Therapeutics Stock

₹49,283 (+49.28%)

Dollar Impact

₹10,396 (+10.4%)

Analyst Recommendation on Candel Therapeutics Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Candel Therapeutics. Average target price of $22.11

Candel Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Candel Therapeutics.

What analysts predicted

62.32%UPSIDE

Target Price

$22.11

Current Price

$8.33

Analyzed by

4 Analysts

High

$25

Target

$22.11

Low

$16

Candel Therapeutics target price $22.11, a slight upside of 62.32% compared to current price of $8.33. According to 4 analysts rating.

Indian Investors' Interest in Candel Therapeutics Stock

Search interest for Candel Therapeutics Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Candel Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-7
-8
-8
-8
-8
-11
-13
-15
-16
-26
EBITDA
-7
-21
-9
-13
7
-4
-10
-27
-7
-37
Interest Expense
0
0
0
0
0
0
0
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Candel Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
-
-
-
Gross Profit
0
0
0
0
-
-
-
Operating Income
-9
-13
-25
-34
-38
-33
-48
EBITDA
-8
-13
-35
-16
-34
-52
-35
Interest Expense
-
-
-
1
2
2
2
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-8
-17
-36
-18
-37
-55
-38
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-8
-17
-36
-18
-37
-55
-38
Net Profit Margin
-5185.60%
100.00%
-11575.20%
100.00%
0.00%
0.00%
0.00%

Candel Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Operating Cash Flow
-8
-6
-6
-5
-8
-8
-10
-10
-18
-17
Investing Cash Flow
0
0
-
0
0
0
0
0
0
0
Financing Cash Flow
-1
1
1
91
-1
17
-3
43
93
23
Change in Cash
-9
-4
-4
86
-10
8
-13
32
75
6

Candel Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-17
-36
-18
-37
-55
-38
Operating Cash Flow
-5
-9
-22
-31
-34
-27
-38
Investing Cash Flow
-35
38
-1
-1
0
0
0
Financing Cash Flow
21
0
71
19
0
94
56
Change in Cash
-18
29
47
-12
-34
67
17

Global Institutional Holdings in Candel Therapeutics

Check out the Institutions with significant holdings in Candel Therapeutics.

Funds
Holdings
Fidelity Select Portfolios
6.36%
Fidelity Mt. Vernon Street Trust
4.64%
Vanguard
4.49%
iShares
4.09%
SPDR
3.60%

Insights on Candel Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CADL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, CADL stock has moved up by 40.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 659.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -8.86M → -38.90M (in $), with an average decrease of 339.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.77M → 1.0M (in $), with an average decrease of 43.7% per quarter

About Candel Therapeutics

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade glioma. Furthermore, the company is advancing CAN-3110, an investigational therapy currently in Phase I clinical trials for recurrent glioblastoma. Established in 2003, the company operated as Advantagene, Inc. until November 2020, when it rebranded as Candel Therapeutics, Inc.
OrganisationCandel Therapeutics
Headquarters117 Kendrick Street, Needham, MA, 02494, US
IndustryBiotechnology
CEOPaul-Peter Tak

Key Management of Candel Therapeutics

Name

Title

Mr. Theodore Jenkins

Vice President of Investor Relations & Business Development

Ms. Ileen B. Winick

Chief People Officer

Ms. Susan Stewart J.D., L.L.M.

Chief Regulatory Officer

Dr. William Nichols Garrett M.D., M.S.

Chief Medical Officer

Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

President, CEO & Director

Mr. Charles Schoch

Senior VP, CFO, Treasurer & Secretary

Dr. Francesca Barone M.D., Ph.D.

Chief Scientific Officer

Dr. Seshu Tyagarajan Ph.D.

Chief Technical & Development Officer

Mr. Mark Sims

Chief Commercial Officer

FAQs

What is Candel Therapeutics share price today?

Candel Therapeutics share price today is $8.33 as on at the close of the market. Candel Therapeutics share today touched a day high of $8.60 and a low of $8.16.

What is the 52 week high and 52 week low for Candel Therapeutics share?

Candel Therapeutics share touched a 52 week high of $14.00 on and a 52 week low of $4.35 on . Candel Therapeutics stock price today i.e. is closed at $8.33,which is 40.50% down from its 52 week high and 91.49% up from its 52 week low.

What is Candel Therapeutics's market capitalisation today?

Candel Therapeutics market capitalisation is $0.00T as on .

How to invest in Candel Therapeutics Stock (CADL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Candel Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Candel Therapeutics Stock (CADL) from India?

Indian investors can start investing in Candel Therapeutics (CADL) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Candel Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Candel Therapeutics share’s latest price of $8.33 as on October 31, 2026 at 8:46 am IST, you will get 1.2005 shares of Candel Therapeutics. Learn more about fractional shares .

What are the returns that Candel Therapeutics has given to Indian investors in the last 5 years?

Candel Therapeutics stock has given -22.97% share price returns and 27.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?